Yair Schneid

This profile gathers the share dealings of Yair Schneid in Galera Therapeutics, Inc. We count 28 filings; the first trade dates from 17 April 2014 and the latest from 19 April 2024.

No open-market sale appears; the market trades are 28 purchases worth €651k. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2024, the count stands at 28 purchases and no sales.

In size, the median ticket on the buying side is €17k. None of the 28 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The latest filing, published on 1 May 2024, reports an open-market purchase of €14k in Galera Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 14 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.